cardisure flavoured 5mg tablets for dogs
eurovet animal health bv - pimobendan - oral bolus, chewable - pimobendan pyridazinone active 5.0 mg/tb - cardiovascular system
cardisure flavoured 10mg tablets for dogs
eurovet animal health bv - pimobendan - oral bolus, chewable - pimobendan pyridazinone active 10.0 mg/tb - cardiovascular system
cardisure flavoured 2.5mg tablets for dogs
eurovet animal health bv - pimobendan - oral bolus, chewable - pimobendan pyridazinone active 2.5 mg/tb - cardiovascular system
cardisure flavoured 1.25mg tablets for dogs
eurovet animal health bv - pimobendan - oral bolus, chewable - pimobendan pyridazinone active 1.25 mg/tb - cardiovascular system
vetmedin 5 mg chewable tablets for dogs
boehringer ingelheim animal health australia pty. ltd. - pimobendan - oral bolus, chewable - pimobendan pyridazinone active 5.0 mg/tb - cardiovascular system - dog | bitch | castrate | puppy - congestive heart failure | dilated cardiomyopathy | mitral and/or tricuspid regur | valvular insufficiency
vetmedin-ca1- pimobendan tablet, chewable
boehringer ingelheim animal health usa inc. - pimobendan (unii: 34ap3bbp9t) (pimobendan - unii:34ap3bbp9t) - vetmedin-ca1 (pimobendan) is indicated for the delay of onset of congestive heart failure in dogs with stage b2 preclinical myxomatous mitral valve disease (2019 acvim consensus statement1 ). stage b2 preclinical myxomatous mitral valve disease (mmvd) refers to dogs with asymptomatic mmvd that have a moderate or loud mitral murmur due to mitral regurgitation and cardiomegaly. do not administer vetmedin-ca1 in cases of hypertrophic cardiomyopathy, aortic stenosis, or any other clinical condition where an augmentation of cardiac output is inappropriate for functional or anatomical reasons. do not administer vetmedin-ca1 to dogs with stage a or b1 preclinical mmvd (2019 acvim consensus statement) due to the risk of cardiac pathology associated with exaggerated hemodynamic responses to vetmedin-ca1.
cardisure 3,5 mg/ml or. sol.
dechra regulatory b.v. - pimobendan 3,5 mg/ml - oral solution - 3,5 mg/ml - pimobendan 3.5 mg/ml - pimobendane - dog
cardisure 1.25 mg tabl.
dechra regulatory b.v. - pimobendan 1,25 mg - tablet - 1,25 mg - pimobendan 1.25 mg - pimobendane - dog
cardisure 2.5 mg tabl.
dechra regulatory b.v. - pimobendan 2,5 mg - tablet - 2,5 mg - pimobendan 2.5 mg - pimobendane - dog
cardisure 5 mg tabl.
dechra regulatory b.v. - pimobendan 5 mg - tablet - 5 mg - pimobendan 5 mg - pimobendane - dog